| Course | DNP 820 Translational Research and Evidence-Based Practice |
|---|---|
| Topic | Topic 5 |
| Paper type | Evidence grading DQ responses |
| Length | About 600 words, 2 pages |
| Format | Discussion post, APA 7 citations |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 820 Topic 5
Topic 5 DQ 1 and DQ 2: Initial Posts and a Reply
Large Trials, a Grade C: PSA Screening and the Gap Between How Good the Evidence Is and How Strongly to Recommend
DQ 1: A Weak Grade From Large Trials Is the System Working
How good the evidence is and how strongly to recommend are separate judgments, and PSA screening for men 55 to 69 shows why a weak grade can follow from large, careful trials. In the European screening trial, with 162,243 men, randomization to PSA screening reduced prostate cancer deaths (relative risk 0.79), but the absolute reduction was 1.1 deaths per 10,000 person-years. Among the men screened in that trial, 17.8 percent had a false-positive result, biopsy complications needing hospitalization affected 0.5 to 1.6 percent of men biopsied in cohort studies, and an estimated 20.7 to 50.4 percent of screen-detected cancers were overdiagnosed. Radical prostatectomy more than doubled the risk of urinary incontinence compared with conservative management (Fenton et al., 2018). The Task Force grades on the certainty and size of net benefit, and a small net benefit at moderate certainty produces a C: the decision to screen should be individual (US Preventive Services Task Force, 2018). The last factor is the one least discussed: men value these outcomes very differently. One man will accept a real chance of incontinence to lower a small risk of dying of prostate cancer; another will not.
I concede that C grades are handled badly in practice, since a busy clinician can hear individual decision as optional. That is a delivery problem, not a grading error. What should change: health systems should attach a decision aid to C-grade services in their preventive care workflows instead of leaving them out.
DQ 2: At the Visit, Individual Decision Often Means No Decision
Grading separates evidence quality from recommendation strength carefully, but at the point of care a C grade often turns into no conversation at all, and that has a cost. The 2018 recommendation expects clinicians to explain benefits and harms and let each man decide (US Preventive Services Task Force, 2018). In a 20-minute annual visit with blood pressure, a medication review and a vaccine to address, the discussion that has no order attached is the one most easily dropped. The men who would have chosen screening, after weighing a small mortality benefit against the risks of overdiagnosis and treatment, lose that choice without being asked.
I accept that the grade itself is right: moderate certainty of a small net benefit is exactly what a C describes, and a stronger grade would push screening on men who would decline it. What should change is the delivery: the Task Force and AHRQ should publish a short patient-facing decision aid alongside every C grade, so the individual decision arrives with a tool.
Reply to Classmate
Jessica, you argue that grading is working as intended and that clinicians only need to read the letter correctly, but here is a case where the distinction broke down after the letter was issued. A primary care group I worked with had an annual physical order set that pre-selected a PSA test for every man aged 50 to 69. It stayed that way for years after the 2018 recommendation called for an individual decision, so the test was drawn before anyone mentioned overdiagnosis or incontinence. A weak recommendation was being carried out as a strong one by an order set nobody reviewed. The Task Force graded correctly, and each clinician could say the test was ordered by default. Who owned that failure: the informatics team that built the order set, the medical director who approved it, or the clinicians who signed it?
References
Fenton, J. J., Weyrich, M. S., Durbin, S., Liu, Y., Bang, H., & Melnikow, J. (2018). Prostate-specific antigen-based screening for prostate cancer: Evidence report and systematic review for the US Preventive Services Task Force. JAMA, 319(18), 1914-1931. https://doi.org/10.1001/jama.2018.3712
US Preventive Services Task Force. (2018). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA, 319(18), 1901-1913. https://doi.org/10.1001/jama.2018.3710
The DNP-820 Topic 5 assignment instructions
Topic 5 in DNP-820 asks students to discuss how evidence is graded and how grades become recommendations. Strong responses separate the quality of the evidence from the strength of the recommendation and show, with a real recommendation, how large and careful trials can still support only a weak recommendation once harms, benefits and patient preferences are weighed. Students should also consider what happens to weak recommendations in practice, where they may be read as permission to do nothing. Replies should test a classmate's claim with a case or figure, and every post should cite the recommendation and the evidence behind it.
How this DNP 820 Topic 5 example is built
The finished example uses a genuinely awkward case. Several well conducted trials establish an effect, and the recommendation drawn from them is weak, because the effect is small, the harm is real and patient preferences vary widely. The first post argues that this is the system working correctly and explains each factor that pulled the strength down despite the quality. The second post presses the opposite way, contending that weak recommendations get read as no recommendation at the bedside and asking what that costs. Both cite the grading approach they are working within. The peer reply raises a specific case where a weak recommendation was implemented as though it were strong, and asks who is responsible for that translation.
Reading the DNP 820 Topic 5 rubric
Faculty reward quality and strength kept apart. An Excellent first response shows how the 2018 US Preventive Services Task Force C grade for PSA screening followed from large trials, using Fenton and colleagues on false positives, biopsy complications and overdiagnosis. Credit goes to a second response arguing that individual decision often becomes no discussion at the visit. The rubric values a reply that tests a classmate's view with a primary care group's experience after the grade was issued. Top marks go to posts tied to the recommendation's actual wording.
DNP 820 Topic 5 help: mistakes that cost marks
Posts equating study quality with recommendation strength are the most common error here and the one the prompt is designed to surface. A second failure is describing a grading approach without applying it to anything, which leaves the vocabulary unattached. Marks also go for ignoring patient preference variability, since it is frequently the factor that pulls a recommendation down and it is the least discussed. Responses that never name a specific case argue about categories. Replies restating the difference between quality and strength add nothing beyond agreement. Posts that exceed the stated length are penalized regardless of how good the argument is. Arguments treating certainty as the only input to strength omit half of what grading systems weigh. Recommendations discussed with no patient in view forget who the guidance is for.
Get a DNP-820 Topic 5 example written to your instructions
Send the DNP-820 Topic 5 prompts and the participation requirements your classroom posts, including length and reply counts. We write custom responses to those criteria, working a real case where good studies support a weak recommendation, with a reply supplying a failure case, in 24 to 48 hours. The first is free.
More DNP 820 papers and DNP samples
- DNP 820 Topic 1: Translation Science Orientation
- DNP 820 Topic 2: Searchable Question Construction
- DNP 820 Topic 3: Appraisal Tool Comparison
- DNP 820 Topic 4: DNP-820 Topic 4: Sample Paper, in Real Form
- DNP 820 Topic 6: Synthesis Arguing a Gap
- DNP 820 Topic 7: Translation Model Selection
- DNP 820 Topic 8: Dissemination Audience Plan
- DNP 825 Topic 5: Policy Lever DQ Pair
- DNP 815A Topic 5: Practice Model Comparison DQ Pair
- DNP 830 Topic 5: Group Comparison with Output
- DNP 810 Topic 5: Emerging Threat DQ Pair
DNP 820 Topic 5 questions, answered
How can strong evidence produce a weak recommendation?
Because strength accounts for more than certainty. A well established effect that is small, carries a real harm, costs a great deal or matters differently to different patients will correctly yield a weak recommendation. The evidence tells you what happens; the recommendation weighs whether most patients would want it. Conflating the two is the standard error here.
Does patient preference really change the grading?
Substantially, and it is the factor most papers omit. Where reasonable people would choose differently given the same information, a strong recommendation would override that variation, which is not what guidelines are for. Naming preference variability as a downgrading factor, with an example of the disagreement, marks a post out immediately.
What is the practical problem with weak recommendations?
They get read as either silence or standard practice, and rarely as what they are, which is an invitation to decide with the patient. That translation failure is worth arguing about, and it is somebody's responsibility. Naming who would own it at a real organization moves the discussion past the theory of grading and into what happens on a ward.
Where can I find a free DNP 820 Topic 5 sample paper?
Two discussion responses on PSA screening grades and a reply to a classmate appear here in full. A post written to your DNP 820 Topic 5 prompt costs nothing.
How can large trials produce a C grade in DNP 820 Topic 5?
Because the grade reflects net benefit, not only evidence quality. For men 55 to 69, a small mortality benefit is balanced against false positives, biopsy harms and overtreatment, so the decision depends on the man's values.